hexadecanesulfonyl fluoride has been researched along with Seizures in 1 studies
AM 374: a palmitylsulfonyl fluoride; inhibits anandamide amidase; structure given in first source
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The KA-induced seizures were associated with calpain-mediated cytoskeletal breakdown, reductions in synaptic markers, and loss of CA1 hippocampal neurons." | 5.34 | Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage. ( Bahr, BA; Karanian, DA; Karim, SL; Lin, S; Makriyannis, A; Williams, JS; Wood, JT, 2007) |
| "The KA-induced seizures were associated with calpain-mediated cytoskeletal breakdown, reductions in synaptic markers, and loss of CA1 hippocampal neurons." | 1.34 | Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage. ( Bahr, BA; Karanian, DA; Karim, SL; Lin, S; Makriyannis, A; Williams, JS; Wood, JT, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karanian, DA | 1 |
| Karim, SL | 1 |
| Wood, JT | 1 |
| Williams, JS | 1 |
| Lin, S | 1 |
| Makriyannis, A | 1 |
| Bahr, BA | 1 |
1 other study available for hexadecanesulfonyl fluoride and Seizures
| Article | Year |
|---|---|
Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Brain; Cannabinoid Receptor Modulators; Endocannabinoid | 2007 |